Ultragenyx Pharmaceutical, Inc. (RARE)
24.70
+0.91
(+3.83%)
USD |
NASDAQ |
Feb 06, 16:00
24.68
-0.02
(-0.06%)
After-Hours: 20:00
Ultragenyx Pharmaceutical SG&A Expense (TTM) : 343.56M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 401.86M |
| Johnson & Johnson | 23.68B |
| CorMedix, Inc. | 75.56M |
| Insmed, Inc. | 631.20M |
| Apellis Pharmaceuticals, Inc. | 524.64M |